AVGO vs CHRS · P/E 87, rev $41.50B vs rev $26.6M
Broadcom Inc (AVGO) versus Coherus BioSciences Inc (CHRS) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. CHRS currently screens at market cap $223.7M.
Not investment advice. Open the AVGO and CHRS stock pages for the full models.
Not investment advice.